[Skip to Content]
[Skip to Content Landing]
April 18, 1942


Author Affiliations

University, Va.

JAMA. 1942;118(16):1389. doi:10.1001/jama.1942.02830160049023

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


To the Editor.—  Dr. Sanford and his associates in an article entitled "Is Administration of Vitamin K to the Newborn of Clinical Value?" (The Journal, February 28, p. 697) seriously question the value of vitamin K in the prophylaxis and treatment of hypoprothrombinemia and associated hemorrhage of the newborn. I am forced to join with Dr. Quick in taking prompt and sharp exception to Dr. Sanford's conclusions.Early in 1939 in a brief preliminary article my associates and I called attention to the prompt and efficient action of vitamin K in the prevention and treatment of hypoprothrombinemia and hemorrhage in the newborn and have repeatedly stated that hemorrhagic disease would not occur in any infant adequately protected with vitamin K. We have also repeatedly expressed the hope, adequately supported by facts, that infant mortality resulting from intracranial hemorrhage will in the future possibly be materially reduced by this sound therapeutic

First Page Preview View Large
First page PDF preview
First page PDF preview